Protection of herpes simplex virus thymidine kinase-transduced cells from ganciclovir-mediated cytotoxicity by bystander cells: The good samaritan effect

Cancer Research

Volumn 57, Issue 9, 1997, Pages 1699-1703

  Wygoda, Marc R ^a   Wilson, Melinda R ^b   Davis, Mary A ^a   Trosko, James E ^b   Rehemtulla, Alnawaz ^a   Lawrence, Theodore S ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ANIMAL CELL; ARTICLE; CELL JUNCTION; CELL PROTECTION; CELL SURVIVAL; DRUG CYTOTOXICITY; DRUG EFFECT; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL COMMUNICATION; CELLS, CULTURED; GANCICLOVIR; GAP JUNCTIONS; GENE THERAPY; RATS; THYMIDINE KINASE; TRANSDUCTION, GENETIC;

EID: 0030916131     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Borrelli, E., Heyman, R., Hsi, M., and Evans, R. M. Targeting of an inducible toxic phenotype in animal cells. Proc. Natl. Acad. Sci. USA, 85: 7572-7576, 1988.
2. Culver, K. W., Ram, Z., Wallbridge, I. H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
3. Moolten, F. L., and Wells, J. M. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst., 82: 297-300, 1990.
4. Smythe, W. R., Hwang, H. C., Amin, K. M., Eck, S. L., Davidson, B. L., Wilson, J. M., Kaiser, L. R., and Albelda, S. M. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSV-TK) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res., 54: 2055-2059, 1994.
5. Hooper, M. L., and Subak-Sharpe, J. H. Metabolic cooperation between cells. Int. Rev. of Cytol., 69: 45-104, 1981.
6. Trosko, J. W., Madhukar, B. V., and Chang, C. C. Endogenous and exogenous modulation of gap junctional intercellular communication: toxicological and pharmacological implications. Life Sci., 53: 1-19, 1993.
7. Wolburg, H., and Rohlmann, A. Structure-function relationships in gap junctions. Int. Rev. Cytol., 157: 315-371, 1995.
8. Pitts, J. D. Cancer gene therapy: a bystander effect using the gap junctional pathway. Mol. Carcinog., 11: 127-130, 1994.
9. Goldberg, G., and Bertram, J. S. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res., 53: 83-88, 1993.
10. Oh, S. Y., Dupont, E., Madhukar, B. V., Briand, J. P., Chang, C. C., Beyer, E., and Trosko, J. E. Characterization of gap junctional communication-deficient mutants of a rat liver epithelial cell line. Eur. J. Cell Biol., 60: 250-255, 1993.
11. Shewach, D. S., Zerbe, L. K., Hughes, T. L., Roessler, B. J., Breakefield, X. O., and Davidson, B. L. Enhanced cytoloxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells. Cancer Gene Ther., 1: 107-112, 1994.
12. Loch-Caruso, R., Pahl, M. S., and Juberg, D. J. Rat myometrial smooth muscle cells show high levels of gap junctional communication under a variety of culture conditions. In Vitro Cell Dev. Biol., 28A: 97-101, 1992.
13. Kalimi, G. H., Hampton, L. L., Trosko, J. E., Thorgeirsson, S. S., and Huggett, A. C. Homologous and heterologous gap-junctional intercellular communication in v-raf-, v-myc-, and v-raflv-myc-transduced rat liver epithelial cell lines. Mol. Carcinog., 5: 301-310, 1992.
14. Lawrence, T. S., Davis, M. A., Maybaum, J., Mukhopadhyay, S. K., Stetson, P. L., Normolle, D. P., McKeever, P. E., and Ensminger, W. D. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer. Cancer Res., 52: 3698-3704, 1992.
15. Chou, T. C., and Talalay, P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul., 22: 27-55, 1984.
16. Bi, W. L., Parysek, L. M., Warnick, R., and Stambrook, P. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV-TK retroviral gene therapy. Hum. Gene Ther., 4: 725-731, 1993.
17. Fick, J., Barker, F. G., Dazin, P., Westphale, E. M., Beyer, E. C., and Israel, M. A. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc. Natl. Acad. Sci. USA, 92: 11071-11075, 1995.
18. Mesnil, M., Piccoli, C., Tirary, G., Willelke, K., and Yamasaki, H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc. Natl. Acad. Sci. USA, 93: 1831-1835, 1996.
19. Tiberghien, P., Reynolds, C. S., Keller, J. R., Murphy, B., Lyons, R., Chiang, Y., Longo, D. L., and Rusletti, F. W. Growth inhibition of herpes simplex thymidine kinase transduced primary T lymphocytes by ganciclovir: lack of a bystander effect. Exp. Ther., 36: 338, 1993.
20. Elshami, A. A., Saavedra, A., Zhang, H., Kucharczuk, J. C., Spray, D. C., Fishman. G. I., Amin, K. M., Kaiser, L. R., and Albelda, S. M. Gap junctions play a role in the "bystander effect" of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther., 4: 85-92, 1996.
21. Shinoura, N., Chen, L., Wani, M. A., Kim, Y. G., Larson, J. J., Warnick, R., Simon, M., Menon, A. G., Bi, W. L., and Stambrook, P. J. Protein and messenger RNA expression of connexin43 in astrocytomas implications in brain tumor gene therapy. J. Neurosurg., 84: 839-845, 1996.
22. Freeman, S. M., Abboud, C. N., Whartenhy, K., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993.
23. Samejima, Y., and Meruelo, D. Bystander killing induces apoptosis and is inhibited by forskolin. Gene Ther., 2: 50-58, 1995.
24. Colombo, B. M., Benedetti, S., Ottolenghi, S., Mora, M., Polio, B., Poli, G., and Finocchiaro, G. The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther., 6: 763-772, 1995.
25. Holder, J. W., Elmomre, E., and Barrett, J. C. Gap junction function and cancer. Cancer Res., 53: 3475-3485, 1993.
26. Ram, Z., Culver, K. W., Walbridge, S., Blaese, R. M. and Oldfield, E. H. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res., 53: 83-88, 1993.
27. Loewenstein, W. R., and Rose, B. The cell-cell channel in the control of growth. Semin. Cell Biol., 3: 59-79, 1992.
28. Hotz-Wagenblatt, A., and Shalloway, D. Gap junctional communication and neoplastic transformation. Oncogenesis, 4: 541-558, 1993.
29. Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmann, J.-L., and Klatzmann, D. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA, 90: 7024-7028, 1993.
30. Freeman, S. M., Whartenby, K. A., Freeman, J. L., Abboud, C. N., and Marrogi, A. J. In situ use of suicide genes for cancer therapy. Semin. Oncol., 23: 31-45, 1996.
31. Freeman, S. M., Ramesh, R., Shastri, M., Munshi, A., Jensen, A. K., and Marrogi, A. J. The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells. Cancer Lett., 92: 167-174, 1995.
32. Trinh, Q. T., Austin, E. A., Murray, D. M., Knick, V. C., and Huber, B. E. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res., 55: 4808-4812, 1995.